EUVIMEDEUVIMED entdecken
Crossref

Saikosaponin D Alleviates Atherosclerosis by Regulating Autophagy and Senescence of VSMCs via Inhibiting EPHB2

Meihua Yan, Tian Tang, Yanxiu Wang, Yuzhen Qin, Qiangwei Hao, Xinri Chen iD, Xianmin Luo

Clinical and Experimental Pharmacology and Physiology · 2026-06 · 53 (6)

DOI: 10.1111/1440-1681.70131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, online erschienen am 16.06.2026. Verfasst von Meihua Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Guangxi International Zhuang Medicine Hospital, Nanning City, Guangxi, China. Hauptthemen laut MEDLINE: Autophagy, Saponins, Atherosclerosis, Oleanolic Acid. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atherosclerosis (AS) is a major cause of cardiovascular diseases, with OX‐LDL‐induced VSMC dysfunction being a critical pathogenic driver of AS development. Saikosaponin D (SSD), a bioactive compound, shows therapeutic potential, but its mechanism in AS is unclear.

Methods

An atherosclerotic cell model was established by treating hVSMCs with OX‐LDL. Intracellular ROS was detected via a fluorescent probe, MDA content and SOD activity via biochemical kits. Inflammatory cytokines (IL‐6, IL‐8 and TNF‐α) were quantified by ELISA. Lipid parameters (TG, LDL and HDL) were analysed biochemically, and intracellular lipid accumulation was assessed via Oil Red O staining. Autophagy (LC3B and p62) and senescence‐related (p16 and p21) protein expression was detected by WB, with cellular senescence further assessed via SA‐β‐gal staining. SSD's potential targets were predicted via bioinformatics (CTD, SwissTargetPrediction and GeneCards). SSD‐EPHB2 interaction was predicted by AutoDock Vina docking (visualised by PyMOL), and its stability was evaluated by using iMODS‐based NMA. EPHB2's functional role was confirmed via its overexpression in hVSMCs.

Results

SSD significantly attenuated OX‐LDL‐induced oxidative stress, inflammation, lipid accumulation, autophagic flux impairment and cellular senescence in hVSMCs. Bioinformatics analysis pinpointed EPHB2 as a hub gene. Molecular studies confirmed that SSD directly binds to EPHB2 and downregulates its expression. Crucially, overexpressing EPHB2 abolished all the protective effects of SSD.

Conclusion

SSD alleviates OX‐LDL‐induced hVSMC dysfunction by inhibiting EPHB2, highlighting the SSD‐EPHB2 pathway as a potential therapeutic target for AS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagySaponinsAtherosclerosisOleanolic AcidCellular SenescenceMuscle, Smooth, VascularReceptor, EphB2Myocytes, Smooth MuscleHumansLipoproteins, LDLOxidative Stress

Stichwörter der Autor:innen

EPH receptor B2atherosclerosisautophagycellular senescencesaikosaponin Dvascular smooth muscle cell

Substanzen

saikosaponin DSaponinsOleanolic AcidReceptor, EphB2Lipoproteins, LDLoxidized low density lipoprotein

Autor:innen und Institutionen

  • Department of Emergency, Guangxi International Zhuang Medicine Hospital, Nanning City, Guangxi, China.
  • Department of Oncology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning City, Guangxi, China.

ORCID-Profile: Xinri Chen

Zitieren

APA

Yan, M., Tang, T., Wang, Y., Qin, Y., Hao, Q., Chen, X., & Luo, X. (2026). Saikosaponin D Alleviates Atherosclerosis by Regulating Autophagy and Senescence of VSMCs via Inhibiting EPHB2. Clinical and Experimental Pharmacology and Physiology, 53(6). https://doi.org/10.1111/1440-1681.70131

Vancouver

Yan M, Tang T, Wang Y, Qin Y, Hao Q, Chen X, et al. Saikosaponin D Alleviates Atherosclerosis by Regulating Autophagy and Senescence of VSMCs via Inhibiting EPHB2. Clinical and Experimental Pharmacology and Physiology. 2026;53(6). doi:10.1111/1440-1681.70131

BibTeX
@article{Yan2026,
  author = {Yan, Meihua and Tang, Tian and Wang, Yanxiu and Qin, Yuzhen and Hao, Qiangwei and Chen, Xinri and Luo, Xianmin},
  title = {Saikosaponin D Alleviates Atherosclerosis by Regulating Autophagy and Senescence of VSMCs via Inhibiting EPHB2},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2026},
  volume = {53},
  number = {6},
  doi = {10.1111/1440-1681.70131}
}
Kostenlos starten →